Waters Corporation — News

The Swiss company agreed with Platinum Equity to create a joint venture and sell a 50% stake in its Waters and Beverages unit.

wsj.com - 2026-07-23 01:34:00

SEATTLE--(BUSINESS WIRE)--PitchBook, a leading private capital market intelligence platform, today announced it has been named “Best Alternative Data Provider” in the Waters Technology Rankings 2026. The award, presented by Waters Technology, a leading publication covering financial technology and data for global capital markets, was decided by crowd-sourced votes from industry professionals across the capital markets technology sector. The Waters Technology Rankings recognize service providers.

businesswire.com - 2026-07-17 09:00:00

Waters Corporation remains a Hold as valuation concerns are balanced by ongoing synergy capture from its Becton, Dickinson acquisition. WAT's Q1 pro forma sales rose to $1.54B, with legacy revenue up 13% and recurring revenue surging 123%, signaling broad-based growth. Synergy realization is on track, with $55M+ cost savings and $50M revenue synergies targeted for 2026, supporting incremental EBITDA gains.

seekingalpha.com - 2026-07-14 11:48:00

MILFORD, Mass., July 2, 2026 /PRNewswire/ -- Waters Corporation (NYSE: WAT) will hold its Q2 2026 financial results conference call on Tuesday, August 4, 2026, at 8:00 a.m.

prnewswire.com - 2026-07-02 06:00:00

LONDON--(BUSINESS WIRE)--IMU Biosciences, a biotechnology company decoding the immune system to pioneer a paradigm shift in how we understand, diagnose, and treat disease, and Waters Corporation (NYSE: WAT) today announced a strategic partnership to accelerate the development of IMU's next-generation AI-powered High Definition (HD) Immunology platform.The partnership brings together Waters Biosciences' advanced flow cytometry and single-cell technologies,1 including BD FACSDiscover Cell Analyzer.

businesswire.com - 2026-06-24 08:00:00

Integrates heat flow, evolved gas, and electrochemical analysis in a single experiment, enabling earlier insights into thermal runaway. Unique whole-cell design eliminates cell teardown, reducing sample preparation time by >90%.

prnewswire.com - 2026-06-09 08:00:00

Faster run times for GLP-1, insulin, and LNP drug substance testing accelerates biopharmaceutical development timelines and reduces production bottlenecks. Delivers up to 2x increase in resolving power and sensitivity to identify and track low-level impurities for improved regulatory readiness.

prnewswire.com - 2026-06-08 08:00:00

Waters (WAT) reported earnings 30 days ago. What's next for the stock?

zacks.com - 2026-06-04 12:35:43

Waters Corporation (WAT) Presents at Jefferies Global Healthcare Conference 2026 Transcript

seekingalpha.com - 2026-06-03 16:02:22

FDA 510(k)-cleared BD BACTEC™ FXI Culture System now available to U.S. market, enabling broader access to confident bloodstream infection diagnostics. Achieves a 3-hour faster time to detection (~15% reduction) versus the prior-generation system, per clinical study data, enabling earlier targeted sepsis prevention.

prnewswire.com - 2026-06-03 08:00:00

Delivers up to 20x improvement in MS/MS sensitivity and 2x faster acquisition speeds, enabling deeper biological insight for next-generation multiomics, therapeutic, and high-throughput workflows. Identifies up to 40% more lipids by LC‑MS/MS than the leading alternative benchtop high‑resolution mass spectrometer, advancing lipidomics research and disease understanding.

prnewswire.com - 2026-06-01 08:00:00

>10x step-change in MS/MS sensitivity paired with multipass Cyclic™ Ion Mobility Spectrometry (IMS) reveals subtle biological differences for earlier, previously unattainable detection of disease signals. 50% extended upper mass range and comprehensive suite of structural tools advance the development of next-generation biotherapeutics.

prnewswire.com - 2026-06-01 08:00:00

Carnival has stabilized after a strong rally, with shares flat since August amid solid fundamentals and macro headwinds. Carnival reported strong Q1 2026 results: 6% revenue growth, 11% operating earnings growth, and adjusted EPS up to $0.20, despite higher share count. 85% of 2026 capacity is already sold, dividend reinstated at $0.15 per quarter, and further deleveraging is underway, though growth is slowing.

seekingalpha.com - 2026-05-31 01:46:03

MILFORD, Mass., May 18, 2026 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that Udit Batra, Ph.D.

prnewswire.com - 2026-05-18 16:00:00

Examine the evolution of Waters' (WAT) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.

zacks.com - 2026-05-14 10:16:11

Waters crushes Q1 2026 estimates as revenues surge 91.5%; newly acquired BD units top targets early, and 2026 guidance moves higher.

zacks.com - 2026-05-07 14:35:42

Conrad Industries is a small-cap shipbuilder trading at a discount to heavy equipment peers, supported by recent revenue and profitability improvements. CNRD shifted from a $27 million net loss in 2023 to a $19.9 million net profit in 2024, with adjusted operating cash flow also turning positive. Despite a declining backlog and order softness, especially in energy, management remains cautiously optimistic for 2026 due to government and infrastructure demand.

seekingalpha.com - 2026-05-06 02:08:21

Waters Corporation (WAT) Q1 2026 Earnings Call Transcript

seekingalpha.com - 2026-05-05 13:41:16

Lab equipment maker Waters raised its annual profit ​forecast on Tuesday after beating quarterly estimates, driven by robust demand for ‌drug development tools and the strong performance of its biosciences and diagnostics unit, acquired last year.

reuters.com - 2026-05-05 10:38:57

Waters (WAT) came out with quarterly earnings of $2.7 per share, beating the Zacks Consensus Estimate of $2.31 per share. This compares to earnings of $2.25 per share a year ago.

zacks.com - 2026-05-05 08:27:07

First Quarter 2026 Highlights Total reported revenue of $1.267 billion exceeded the high end of the guidance range by $56 million, driven by strong outperformance in both organic revenue and the acquired businesses. Organic revenue grew 13% as reported and 11% in constant currency, exceeding the high end of the constant currency growth guidance range by 200 basis points – led by high-single-digit instrument growth and mid-teens chemistry growth within the Analytical Sciences Division.

prnewswire.com - 2026-05-05 06:00:00

Teleflex (TFX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

zacks.com - 2026-04-30 11:06:38

Waters (WAT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

zacks.com - 2026-04-29 13:10:16

Waters (WAT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

zacks.com - 2026-04-28 11:10:04